<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03133156</url>
  </required_header>
  <id_info>
    <org_study_id>2016-33</org_study_id>
    <secondary_id>R01DK112283</secondary_id>
    <nct_id>NCT03133156</nct_id>
  </id_info>
  <brief_title>Exercise Regulation of Human Adipose Tissue</brief_title>
  <official_title>Exercise Regulation of Human Adipose Tissue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joslin Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Joslin Diabetes Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether exercise training leads to changes in the&#xD;
      white adipose tissue that are beneficial to the body's regulation of sugar and body weight.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of obesity and type 2 diabetes in the United States and worldwide has risen&#xD;
      dramatically over the last few decades, resulting in an enormous need for new therapies to&#xD;
      treat these conditions. The discovery that beiging of subcutaneous white adipose tissue may&#xD;
      increase energy expenditure has led to tremendous interest in beige cells as a potential&#xD;
      treatment for diabetes and obesity. An established treatment for type 2 diabetes and obesity&#xD;
      is endurance exercise training. Exercise training can improve systemic homeostasis, and&#xD;
      although adaptations to skeletal muscle play a critical role in these effects, the underlying&#xD;
      mechanisms are not fully understood. Moreover, the contributions of other tissues in these&#xD;
      beneficial effects of exercise on metabolism have not been intensively investigated. The&#xD;
      study team hypothesizes that exercise training results in fundamental changes to white&#xD;
      adipose tissue, including beiging, and these adaptations play an important role in the&#xD;
      effects of exercise training to improve metabolic homeostasis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>The current research will consist of 2 different exercise training protocols. Subjects will be randomized into each Arm based on screening criteria and compared to the control (Arm 1)</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in human adipose tissue characteristics following exercise training.</measure>
    <time_frame>Change from baseline adipose tissue characteristics following 10 weeks of exercise training.</time_frame>
    <description>Effects of exercise training on adipose tissue in humans.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Healthy</condition>
  <condition>Obese</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Moderate Intensity Training-Healthy Lean</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eligible subjects will undergo a 10-week moderate intensity exercise program.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Intensity Training-Healthy Overweight/Obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eligible subjects will undergo a 10-week moderate intensity exercise program.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Intensity Training-Overweight/Obese Type 2 Diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eligible subjects will undergo a 10-week moderate intensity exercise program.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Intensity Training-Healthy Lean.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eligible subjects will undergo a 10-week high intensity exercise program</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise Intervention</intervention_name>
    <description>10-Week Aerobic Exercise Training</description>
    <arm_group_label>High Intensity Training-Healthy Lean.</arm_group_label>
    <arm_group_label>Moderate Intensity Training-Healthy Lean</arm_group_label>
    <arm_group_label>Moderate Intensity Training-Healthy Overweight/Obese</arm_group_label>
    <arm_group_label>Moderate Intensity Training-Overweight/Obese Type 2 Diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 25-55 years old at the time of screening&#xD;
&#xD;
          -  Body mass index (BMI) must be:&#xD;
&#xD;
               -  ≥20 and ≤ 27 kg/m2 for lean subjects&#xD;
&#xD;
               -  ≥25 and ≤ 37 kg/m2 for subjects with type 2 diabetes&#xD;
&#xD;
               -  ≥27 and ≤ 37 kg/m2 for obese/overweight subjects&#xD;
&#xD;
          -  HbA1c values:&#xD;
&#xD;
               -  ≤5.7 ± 0.1% for lean and overweight/obese subjects&#xD;
&#xD;
               -  6.5 ± 0.1% - 9.0 ± 0.1% for subjects with type 2 diabetes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;25 and &gt;55 years old&#xD;
&#xD;
          -  Type 1 Diabetes&#xD;
&#xD;
          -  HbA1c ≥ 9.0%&#xD;
&#xD;
          -  Heart or lung disease&#xD;
&#xD;
          -  Basal-Bolus Insulin regimen&#xD;
&#xD;
          -  Use of beta-blockers or thiazolidinediones&#xD;
&#xD;
          -  Acute systemic infection accompanied by fever, body aches, or swollen lymph glands&#xD;
&#xD;
          -  BMI ≥ 37 kg/m2&#xD;
&#xD;
          -  Current dieting or weight loss efforts&#xD;
&#xD;
          -  Current pregnant or breastfeeding&#xD;
&#xD;
          -  Known history of HIV/AIDS or certain cancers&#xD;
&#xD;
          -  Biochemical evidence of renal or hepatic dysfunction; renal or liver disease&#xD;
&#xD;
          -  Demyelinating diseases such as multiple sclerosis or amyotrophic lateral sclerosis&#xD;
&#xD;
          -  Recent blood donation&#xD;
&#xD;
          -  Clinical history of stroke&#xD;
&#xD;
          -  Severe hypertension (systolic &gt; 160 mmHg or diastolic &gt; 90 mmHg)&#xD;
&#xD;
          -  Inability to exercise at 50% of predicted heart rate (HR) reserve at baseline&#xD;
&#xD;
          -  Participants who screen positive for The American Heart Association's&#xD;
             contraindications to exercise testing&#xD;
&#xD;
          -  History of keloid formation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurie J Goodyear, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Joslin Diabetes Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Simpson</last_name>
    <phone>6173094378</phone>
    <email>exercise.research@joslin.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Joslin Diabetes Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Simpson</last_name>
      <phone>617-309-4378</phone>
      <email>exercise.research@joslin.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Laurie J Goodyear, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 22, 2017</study_first_submitted>
  <study_first_submitted_qc>April 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2017</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise</keyword>
  <keyword>Training</keyword>
  <keyword>Type 2 Diabetes</keyword>
  <keyword>Mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

